Brought to you by:
Less vain and more vein: Evaluating the perceptions of venous disease amongst the vascular surgery community
Our biases permeate the fabric of our very being, as they weave their way into our training and practice. It is clear that complex aortic work is definitely in vogue and “in,” and, well… treating veins gets a bad rap.…
‘There is no reliable way to measure carotid stenosis—methods have changed and tend to overestimate the degree of narrowing’
The recent move to expand Medicare coverage of carotid stenting formed the basis of a recent debate over the wisdom of the decision taken by the Centers for Medicare & Medicaid Services (CMS). Two heavyweights in the stroke arena went…
Need for ‘clear, well-defined guidelines’ in patient selection for surgical implantation of baroreflex activation therapy devices identified
The emergence of a baroreflex activation therapy device for heart failure patients is drawing in the assistance of the open surgical expertise of vascular surgeons in the arena of the carotid bulb— and drawing attention to a need for “clear…
Bylaws referendum approved by SVS voting members
The voting members of the SVS have approved amendments to the Society bylaws following a referendum that closed on Nov. 20. The proposed changes were focused on two areas: adjustments to membership privileges for early-career members and adjustments to the…
SVS makes fresh call for active participation in compensation survey
The Society for Vascular Surgery (SVS) has made a fresh call for members to participate in a compensation survey, a collaboration with Phairify, that aims to provide vascular surgeons with tailored insights into compensation, practice and productivity data relevant to…
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for ‘relatively benign’ disease trend upward
In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the bold statement during the recent 2023 VEITHsymposium (Nov. 14–18) as he pointedly asked a room full…
Enrollment complete in APEX-AV study of mechanical aspiration system for acute PE
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for the treatment of acute intermediate-risk pulmonary embolism (PE). APEX-AV is a single-arm investigational device exemption (IDE)…
The top 10 most popular Vascular Specialist stories of November 2023
In November, the most read stories from Vascular Specialist include a reassessment of which carotid revascularization treatment modality is best after the recent Centers for Medicare & Medicaid Services (CMS) coverage expansion; updated analyses from the VOYAGER PAD clinical trial;…
Intravenous anesthesia delivery during varicose vein treatment proves safe and reduces pain scores, researcher reports
A new intravenous anesthesia delivery technique used during endothermal ablation for varicose veins demonstrated comparatively low pain scores according to first-in-human (FIH) data recently presented at the 2023 VEITHsymposium. The investigational Solutio catheter (MedVasc), which contains both a bent needle…
VOYAGER PAD analyses shed light on use of rivaroxaban in high-risk patient populations
New analyses from the VOYAGER PAD clinical trial in both high-risk and fragile patients and those with and without comorbid coronary artery diseases (CAD) were presented at the American Heart Association (AHA) 2023 Scientific Sessions (Nov. 11–13) in Philadelphia. The…